You are here » Home » Markets » Mutual Funds

Nippon India Pharma Fund - Direct (Bonus)

Fund Class : Equity - Pharma
Fund House : Nippon India Mutual Fund
Aum(Rs Cr) : 653.56
NAV 07 Aug 2020 228.29 -1.36
(-0.59%)

NAV High-Low (in Rs)

ONE Mth
52-WEEk 2189.84
3092.66

Trailing Returns

% 1-week 1-Mth 6-Mths 1-Yr 3-Yrs
Schemes 1.52 13.75 33.16 56.17 19.86
Sensex 1.15 3.72 -7.54 3.68 17.87
Nifty 1.27 3.84 -7.31 3.3 11.5

Fund Features

Types of Scheme Dividend
Options Equity
Assets Size (Rs in Cr) 653.56 (31 Jan 13)
Inception Date 01 Jan 13
Fund Manager Sailesh Raj Bhan

Investment Details

Minimum Investment 5000.00
Purchase Redemption DAILY
Last Dividend paid (Rs)
Entry Load 0.00%
EXIT Load 0.00.

Fund Activity

   As On 30 Jun 2020
Category Share (%)
Cash & Cash Equivalent 0.00
Derivatives 0.04
Equity 98.07
Reverse Repo 2.02
› More
   As On 30 Jun 2020
Sector Name Amount
Healthcare 13.13
NA 2.06
Pharmaceuticals - Indian - Bulk Drugs 17.17
Pharmaceuticals - Indian - Bulk Drugs & Formln 58.33
Pharmaceuticals - Indian - Formulations 1.34
Pharmaceuticals - Multinational 8.10
› More
   As On 30 Jun 2020
Company Name
Aurobindo Pharma 10.48
Cipla 9.94
Sun Pharma.Inds. 9.64
Dr Reddy's Labs 9.50
Lupin 9.43
Divi's Lab. 7.74
Syngene Intl. 6.35
Fortis Health. 5.68
› More

Fund DETAILS

Asset Management Co.

Registered Address

Nippon Life Asset Management Ltd,

Reliance Center 7th Floor South
Wing Off Western Express
Highway Santacruz(E) Mumbai-400055

Phone: 022-43031000/1860 266 0111 | Fax: 022-43037662

Email: customercare@nipponindiamf.com

Website: www.nipponindiamf.com